Impact of Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography on Therapeutic Decisions and Radiotherapy Planning in Head and Neck Squamous Carcinoma: A Retrospective Study of 46 Patients

Anh Pham; Ildiko Garai; Kovács Árpád; Ádám Dér; Erika Szanto; Zsolt Hascsi; Ferenc Bátyi; Ervin Berényi; Thong Minh Pham

doi:10.12659/MSM.942122

20 January 2024: Clinical Research

Impact of Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography on Therapeutic Decisions and Radiotherapy Planning in Head and Neck Squamous Carcinoma: A Retrospective Study of 46 Patients

Anh Pham ^1ABDF* , Ildiko Garai ^2ADE , Kovács Árpád ^3A , Ádám Dér ^3DE , Erika Szanto ^3DE , Zsolt Hascsi ^2A , Ferenc Bátyi ^2B , Ervin Berényi ^2A , Thong Minh Pham ^1A

DOI: 10.12659/MSM.942122

Med Sci Monit 2024; 30:e942122

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions References

View HTML version

Table 1 Baseline characteristics of the 46 patients that were included in this study.

Characteristic		N	Percentage (%)
Age (years)	Mean	62
Age (years)	Range	46–78
Gender	Male	44	95.65
Gender	Female	2	4.35
Histology	Squamous cell carcinoma	45	97.8
Histology	Sarcoid cell carcinoma	1	2.2

Back to the Article

Impact of Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography on Therapeutic Decisions and Radiotherapy Planning in Head and Neck Squamous Carcinoma: A Retrospective Study of 46 Patients

Your Privacy